Triazole appending agent (TAAG): A new synthon for preparing iodine-based molecular imaging and radiotherapy agents

ACS Medicinal Chemistry Letters

Volumn 3, Issue 4, 2012, Pages 313-316

  Darwish, Alla ^a   Blacker, Megan ^b   Janzen, Nancy ^a   Rathmann, Stephanie M ^a   Czorny, Shannon ^a   Hillier, Shawn M ^c   Joyal, John L ^c   Babich, John W ^c   Valliant, John F ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Centre for Probe Development and Commercialization   (Canada)

^c Clinical Research   (United States)

Author keywords

imaging; iodine; radiochemistry; radiopharmaceuticals; SPECT

Indexed keywords

IODINE 123; IODOBENZOIC ACID DERIVATIVE; PROSTATE SPECIFIC MEMBRANE ANTIGEN; RADIOACTIVE IODINE; TRIAZOLE; TRIAZOLE APPENDING AGENT; TRIBUTYLTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG SYNTHESIS; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 84859783659     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml300003v     Document Type: Article

References (40)

1. Rösch, F.; Baum, R. P. Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS Dalton Trans. 2011, 40, 6104-6111
2. Agdeppa, E. D.; Spilker, M. E. A review of imaging agent development AAPS J. 2009, 11, 286-299
3. Lammers, T.; Aime, S.; Hennink, W. E.; Storm, G.; Kiessling, F. Theranostic Nanomedicines Acc. Chem. Res. 2011, 44, 1029-1038
4. 90Y antibodies Eur. J. Nucl. Med. Mol. Imaging 2011, 38 (Suppl. 1) S28-S40
5. Garg, P. K.; Slade, S. K.; Harrison, C. L.; Zalutsky, M. R. Labeling proteins using aryl iodide acylation agents: influence of meta vs para substitution on in vivo stability Nucl. Med. Biol. 1989, 16, 669-673 (Pubitemid 19269399)
6. 131I]SIPMB), a Negatively Charged Substituent-Bearing Acylation Agent for the Radioiodination of Peptides and mAbs Bioconjugate Chem. 2003, 14, 331-341 (Pubitemid 36348656)
7. Vaidyanathan, G.; Zalutsky, M. R.; DeGrado, T. R. Iodopyridine-for- Iodobenzene Substitution for Use with Low Molecular Weight Radiopharmaceuticals: Application to m-Iodobenzylguanidine Bioconjugate Chem. 1998, 9, 758-764 (Pubitemid 28542244)
8. Garg, S.; Garg, P. K.; Zalutsky, M. R. N-Succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: A new class of reagents for protein radioiodination Bioconjugate Chem. 1991, 2, 50-56
9. Foulon, C. F.; Alston, K. L.; Zalutsky, M. R. Synthesis and Preliminary Biological Evaluation of (3-Iodobenzoyl)norbiotinamide and ((5-Iodo-3-pyridinyl) -carbonyl)norbiotinamide: Two Radioiodinated Biotin Conjugates with Improved Stability Bioconjugate Chem. 1997, 8, 179-186 (Pubitemid 27153291)
10. Reist, C. J.; Garg, P. K.; Alston, K. L.; Bigner, D. D.; Zalutsky, M. R. Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate Cancer Res. 1996, 56, 4970-4977 (Pubitemid 26374437)
11. 125I-Labeled Trifunctional Reagent for Multiscale Imaging with Optical and Nuclear Techniques Angew. Chem., Int. Ed. 2011, 50, 6793-6795
12. 125I-Labeled Trifunctional Reagent for Multiscale Imaging with Optical and Nuclear Techniques Angew. Chem. 2011, 123, 6925-6927
13. Avory, M.; Trigg, W. GE Healthcare Limited, WO 2011020907.
14. Hanamoto, T.; Hakoshima, Y.; Egashira, M. Tributyl(3,3,3-trifluoro-1- propynyl)stannane as an efficient reagent for the preparation of various trifluoromethylated heterocyclic compounds Tetrahedron Lett. 2004, 45, 7573-7576 (Pubitemid 39243326)
15. Ito, S.; Hirata, Y.; Nagatomi, Y.; Satoh, A.; Suzuki, G.; Kimura, T.; Satow, A.; Maehara, S.; Hikichi, H.; Hata, M.; Ohta, H.; Kawamoto, H. Discovery and biological profile of isoindolinone derivatives as novel metabotropic glutamate receptor 1 antagonists: A potential treatment for psychotic disorders Bioorg. Med. Chem. Lett. 2009, 19, 5310-5313
16. Sakamoto, T.; Uchiyama, D.; Kondo, Y.; Yamanaka, H. Synthesis and reaction of 1-phenyl-4-(trimethylstannyl)-1,2,3-triazoles Heterocycles 1993, 35, 1273-1278
17. Ito, S.; Satoh, A.; Nagatomi, Y.; Hirata, Y.; Suzuki, G.; Kimura, T.; Satow, A.; Maehara, S.; Hikichi, H.; Hata, M.; Kawamoto, H.; Ohta, H. Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as an orally active new class of metabotropic glutamate receptor 1 antagonist Bioorg. Med. Chem. 2008, 16, 9817-9829
18. Ali, H.; vanLier, J. E. Synthesis of radiopharmaceuticals via organotin intermediates Synthesis 1996, 4, 423-438
19. Donovan, A.; Forbes, J.; Dorff, P.; Schaffer, P.; Babich, J.; Valliant, J. F. A New Strategy for Preparing Molecular Imaging and Therapy Agents Using Fluorine-Rich (Fluorous) Soluble Supports J. Am. Chem. Soc. 2006, 128, 3536-3537
20. 18F]fluoride ion: Nucleophilic fluorination as the detagging process Angew. Chem., Int. Ed. 2009, 48, 586-589
21. 18F]fluoride ion: Nucleophilic fluorination as the detagging process Angew. Chem. 2009, 121, 594-597
22. Nygren, C. L.; Wilson, C. C.; Turner, J. F. C. On the Solid State Structure of 4-Iodobenzoic Acid J. Phys. Chem. A 2005, 109, 2586-2593 (Pubitemid 40407784)
23. Li, Y.-C.; Qi, C.; Li, S.-H.; Zhan, H.-J.; Sun, C.-H.; Yu, Y.-Z.; Pang, S.-P. 1,1′-Azobis-1,2,3-triazole: A High-Nitrogen Compound with Stable N8 Structure and Photochromism J. Am. Chem. Soc. 2010, 132, 12172-12173
24. Domnin, I. N.; Remizova, L. A.; Starova, G. L.; Rominger, F. Synthesis and properties of 5-alkynyl-1,2,3-triazoles Russ. J. Org. Chem. 2009, 45, 1678-1682
25. Maresca, K. P.; Marquis, J. C.; Hillier, S. M.; Lu, G.; Femia, F. J.; Zimmerman, C. N.; Eckelman, W. C.; Joyal, J. L.; Babich, J. W. Novel Polar Single Amino Acid Chelates for Technetium-99m Tricarbonyl-Based Radiopharmaceuticals with Enhanced Renal Clearance: Application to Octreotide Bioconjugate Chem. 2010, 21, 1032-1042
26. Nan, F.; Bzdega, T.; Pshenichkin, S.; Wroblewski, J. T.; Wroblewska, B.; Neale, J. H.; Kozikowski, A. P. Dual Function Glutamate-Related Ligands: Discovery of a Novel, Potent Inhibitor of Glutamate Carboxypeptidase II Possessing mGluR3 Agonist Activity J. Med. Chem. 2000, 43, 772-774 (Pubitemid 30152285)
27. Kozikowski, A. P.; Nan, F.; Conti, P.; Zhang, J. H.; Ramadan, E.; Bzdega, T.; Wroblewska, B.; Neale, J. H.; Pshenichkin, S.; Wroblewski, J. T. Design of Remarkably Simple, Yet Potent Urea-Based Inhibitors of Glutamate Carboxypeptidase II (NAALADase) J. Med. Chem. 2001, 44, 298-301 (Pubitemid 32113579)
28. Maresca, K. P.; Hillier, S. M.; Femia, F. J.; Keith, D.; Barone, C.; Joyal, J. L.; Zimmerman, C. N.; Kozikowski, A. P.; Barrett, J. A.; Eckelman, W. C.; Babich, J. W. A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer J. Med. Chem. 2009, 52, 347-357
29. Chen, Y.; Foss, C. A.; Byun, Y.; Nimmagadda, S.; Pullambhatla, M.; Fox, J. J.; Castanares, M.; Lupold, S. E.; Babich, J. W.; Mease, R. C.; Pomper, M. G. Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer J. Med. Chem. 2008, 51, 7933-7943
30. Foss, C. A.; Mease, R. C.; Fan, H.; Wang, Y.; Ravert, H. T.; Dannals, R. F.; Olszewski, R. T.; Heston, W. D.; Kozikowski, A. P.; Pomper, M. G. Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen: In vivo Imaging in Experimental Models of Prostate Cancer Clin. Cancer Res. 2005, 11, 4022-4028 (Pubitemid 40791565)
31. Hillier, S. M.; Maresca, K. P.; Femia, F. J.; Marquis, J. C.; Foss, C. A.; Nguyen, N.; Zimmerman, C. N.; Barret, J. A.; Eckelman, W. C.; Pomper, M. G.; Joyal, J. L.; Babich, J. W. Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer Cancer Res. 2009, 69, 6932-6940
32. 123I-MIP-1072, a small-molecule inhibitor of prostate-specific membrane antigen, is effective at monitoring tumor response to taxane therapy J. Nucl. Med. 2011, 52, 1087-1093
33. Stanbury, J. B. Deiodination of the iodinated amino acids Ann. N.Y. Acad. Sci. 1960, 86 II, 417-439
34. Won, C. M. Kinetics of degradation of levothyroxine in aqueous solution and in solid state Pharm. Res. 1992, 9, 131-137
35. 123I]iodo-4-oxo-1,4-dihydroquinoline-2-carboxylic acid Appl. Radiat. Isot. 1997, 48, 1173-1177 (Pubitemid 28015205)
36. 1A Receptor J. Med. Chem. 2011, 54, 3480-3491
37. Choi, T. H.; Ahn, S. H.; Kwon, H. C.; Choi, C. W.; Awh, O. D.; Lim, S. M. In vivo comparison of IVDU and IVFRU in HSV1-TK gene expressing tumor bearing rats Appl. Radiat. Isot. 2004, 60, 15-21 (Pubitemid 37542331)
38. 18F]fluoropeptides using CuI catalyzed 1,3-dipolar cycloaddition Tetrahedron Lett. 2006, 47, 6681-6684 (Pubitemid 44176106)
39. 18F-Labeling of RGD Peptides and microPET Imaging of Tumor Integrin αvβ3 Expression Bioconjugate Chem. 2007, 18, 1987-1994 (Pubitemid 350220000)
40. 18F]Fluoroethylazide for Positron Emission Tomography Bioconjugate Chem. 2007, 18, 989-993 (Pubitemid 47010823)